Lescol (fluvastatin sodium)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Approval Status:

Approved September 1997

Specific Treatments:

coronary atherosclerosis

Find Related Trials for The Following Conditions

General Information

Lescol has been approved for a new indication--a treatment to decrease the progression of coronary atherosclerosis in patients with coronary heart disease undergoing treatment programs to lower lipoprotein cholesterol. Lescol was originally approved in 1994 for patients with primary hypercholesterolemia.